P0926AH-B FOXBORO

It is reported that since 2021,the domestically produced Jingfeng®porous surgical robot has launched several rounds of clinical trials in the fields of urology and gynecology,and in April 2022,it has obtained the qualification for rapid review of innovative medical devices by the State Food and Drug Administration.Among them,the Department of Urology will complete the clinical registration trial enrollment in November 2021.Professor Zhang Xu of Chinese People’s Liberation Army General Hospital,Professor Lin Tianxin of Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Professor Zhou Fangjian of Sun Yat-sen University Cancer Center and Professor of the First Affiliated Hospital of Zhengzhou University Zhang Xuepei jointly carried out.The first registered clinical operation in gynecology was carried out in December 2021,and was completed by Professor Meng Yuanguang and his team from the General Hospital of the Chinese People’s Liberation Army.

据悉,2021年至今,国产精锋®多孔手术机器人已在泌尿外科、妇科领域展开了多轮的临床试验,并于2022年4月,获得国家药监局有关创新医疗器械的快速审查资格。其中泌尿外科于2021年11月完成临床注册试验入组,由中国人民解放军总医院教授张旭、中山大学孙逸仙纪念医院教授林天歆、中山大学肿瘤防治中心教授周芳坚和郑州大学第一附属医院教授张雪培共同开展。首例妇科注册临床手术于2021年12月开展,由中国人民解放军总医院孟元光教授及其团队完成。